J Korean Med Assoc.  2006 Apr;49(4):358-368. 10.5124/jkma.2006.49.4.358.

Allergic Rhinitis

• Dhong HJ

• KMID: 1958290
• DOI: http://doi.org/10.5124/jkma.2006.49.4.358

Abstract

Allergic rhinitis is defined as an immunologic response moderated by IgE and is characterized by sneezing, rhinorrhea, nasal congestion, and nasal itching. Allergic rhinitis represents a global health problem. It is an extremely common disease worldwide affecting 10 to 25% of the population. Because of its increasing prevalence over the last decades, allergic rhinitis has been identified as one of the top ten reasons for visits to primary care clinics. Although allergic rhinitis is not a severe disease usually, it significantly affects the social life of patients and compromises school performance as well as work productivity. In addition, allergic rhinitis is associated with asthma, sinusitis, otitis media, nasal polyposis, lower respiratory tract infection and dental occlusion. Therefore, the cost incurred by rhinitis is substantial. Allergic rhinitis was previously classified into seasonal, perennial, and occupational. From a therapeutic point of view, however, it is often difficult to differentiate between seasonal and perennial symptoms. In 2001, therefore, a new classification has been proposed by the ARIA as 'ntermittent' or 'persistent' rhinitis. The severity of allergic rhinitis can be classified as 'mild' or 'moderate-severe' on the basis of symptoms as well as the quality of life of the patient. Treatment of allergic rhinitis involves allergen avoidance, pharmacotherapy, and in selected cases, immunotherapy. Surgical procedures can be performed in refractory cases. This article reviews the predisposing factors to allergic rhinitis, clinical presentation, diagnosis, and the recommended treatment options.

Keyword

Allergic rhinitis; Classification; Pharmacotherapy; Immunotherapy; Surgical procedure

MeSH Terms

Asthma
Causality
Classification
Dental Occlusion
Diagnosis
Drug Therapy
Efficiency
Estrogens, Conjugated (USP)
Humans
Immunoglobulin E
Immunotherapy
Otitis Media
Prevalence
Primary Health Care
Pruritus
Quality of Life
Respiratory Tract Infections
Rhinitis*
Seasons
Sinusitis
Sneezing
Estrogens, Conjugated (USP)
Immunoglobulin E

Reference

1. Pawankar R. Allergic rhinitis and asthma: the link, the new ARIA classification and global approaches to treatment. Curr Opin Allergy Clin Immunol. 2004. 4:1–4.

2. Cho SH, Kim YK, Shon JW, Kim WK, Lee SR, Park JK, et al. Prevalence of chronic rhinitis in Korean children and adolescents. J Asthma Allergy Clin Immunol. 1999. 19:452–458.

3. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001. 108:S147–S334.

4. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001. 108:S2–S8.

5. Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol. 1999. 82:233–248. quiz 48 - 52.

6. Tang RB, Tsai LC, Hwang HM, Hwang B, Wu KG, Hung MW. The prevalence of allergic disease and IgE antibodies to house dust mite in schoolchildren in Taiwan. Clin Exp Allergy. 1990. 20:33–38.

7. Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol. 1997. 99:S773–S780.

8. Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998. 81:478–518.

9. Sheikh A, Hurwitz B. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev. 2001. CD001563.

10. Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol. 2000. 105:S622–S627.

11. Van Cauwenberge P, Juniper EF. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy. 2000. 30:891–899.

12. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998. 317:1624–1629.

13. Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002. 89:479–484.

14. LaForce C. Use of nasal steroids in managing allergic rhinitis. J Allergy Clin Immunol. 1999. 103:S388–S394.

15. Juniper EF, Stahl E, Doty RL, Simons FE, Allen DB, Howarth PH. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol. 2005. 115:S390–S413.

16. Garbe E, LeLorier J, Boivin JF, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. Jama. 1997. 277:722–727.

17. Pleskow W, Grubbe R, Weiss S, Lutsky B. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2005. 94:348–354.

18. Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol. 1995. 95:1097–1110.

19. Laursen LC, Faurschou P, Pals H, Svendsen UG, Weeke B. Intramuscular betamethasone dipropionate vs. oral prednisolone in hay fever patients. Allergy. 1987. 42:168–172.

20. Milgrom H, Biondi R, Georgitis JW, Meltzer EO, Munk ZM, Drda K, et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol. 1999. 83:105–111.

21. Yang X. Does allergen immunotherapy alter the natural course of allergic disorders? Drugs. 2001. 61:365–374.

22. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies. Clin Ther. 2000. 22:329–341.

23. Imamura S, Honda H. Carbon dioxide laser vaporization of the inferior turbinate for allergic rhinitis: short-term results. Ann Otol Rhinol Laryngol. 2003. 112:1043–1049.

24. Lin HC, Lin PW, Su CY, Chang HW. Radiofrequency for the treatment of allergic rhinitis refractory to medical therapy. Laryngoscope. 2003. 113:673–678.

25. Takeno S, Osada R, Ishino T, Yajin K. Laser surgery of the inferior turbinate for allergic rhinitis with seasonal exacerbation: an acoustic rhinometry study. Ann Otol Rhinol Laryngol. 2003. 112:455–460.

26. Tsai YL, Chang CC, Lee HS, Chen MK. Outcome survey of therapy with diode laser in patients with allergic rhinitis. J Otolaryngol. 2005. 34:38–40.